COMP <GO>
VMD vs PARK // EV/EBITDA & P/E VALUATION
Viemed Healthcare Inc. (NASDAQ) VS. Park Dental Partners Inc. (NASDAQ) • 15-METRIC TALLY: VMD 1
— PARK 1
■ METRIC PARITY
LAST: $9.95 (-0.40%) • MKT CAP: $379.0M
valuation
6.6x
LAST: $20.06 (-2.79%) • MKT CAP: $95.4M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VMD VS. PARK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VMD | PARK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 6.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.15% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 8.50% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 5.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 20.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.59 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 57.9 | -4.76 | PARK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $379.0M | $95.4M | $283.6M | VMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VMD REV | PARK REV | VMD GROSS % | PARK GROSS % | VMD FCF | PARK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $270.3M | $0 | 57.5% | — | $11.9M | — |
| FY 2024 | $224.3M | — | 59.4% | — | $1.3M | — |
| FY 2023 | $183.0M | — | — | — | $45.2M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VMD // BETA —
PARK // BETA —